Company intelligence / Profile preview

Slate Run Pharmaceuticals

Columbus, Ohio, United Statesslaterunpharma.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Slate Run Pharmaceuticals is an active U.S.-based pharmaceutical manufacturer focused on providing a reliable and sustainable supply of FDA-approved generic injectables and oral solid medications. All products are approved by the FDA and meet rigorous quality standards. The company emphasizes consistent supply, quality manufacturing, and responsive customer service. Their leadership team has over a century of combined experience in the generics industry[1][3][5][7].

Therapeutic areas: PulmonologyEndocrinologyImmunologyOtherCardiovascularNeurologyInfectious Diseases
Modalities: Small molecules (generic oral solids and injectables)[1][6]
Industry: Biotech

Partnerships

Assists non-U.S.-based companies with U.S. market entry for generics; specific partners not named publicly[2][10].

Beyond the preview

Go deeper on Slate Run Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Slate Run Pharmaceuticals.